Each tablet contains 5mg Nitrazepam.
Mogam has essential effects on CNS, and it is one of the 1,4 Benzodiazepines groups. It is similar to this group in its effects and has sedative properties.
Mogam is indicated for a short term treatment of severe insomnia.
Sensitivity to benzodiazepines, acute pulmonary insufficiency and chronic psychosis.
The common side effects: Drowsiness, sedation, blurring of vision and ataxia. Other side effects, which occur rarely such as: Headache, dizziness, gastrointestinal disturbances and skin rashes.
If Mogam is combined with centrally acting drugs such as: Neuroleptics, tranquilizers, antidepressants, hypnotics, analgesics, and anesthetics, the sedative effects are likely to be intensified. When Mogam is used in conjunction with antiepileptic drugs, side effects and toxicity may be more evident particularly with hydantoin or barbiturates. Inhibitors of hepatic enzymes, e.g. cimetidine, reduce the clearance of benzodiazepines and may potentiate their action. The inducers of hepatic enzymes, e.g. rifampicin, may increase the clearance of Mogam.
USE IN PREGNANCY OR LACTATION:
For compelling medical reason it can be administered during the late phase of pregnancy. But nursing woman should not use it.